⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
HbA1c (glycated haemoglobin) reflects your average blood glucose over the previous 2-3 months. Unlike a fasting blood sugar test — a single-moment snapshot — HbA1c tells you and your doctor the overall pattern of glucose control. For patients on semaglutide (Ozempic, Rybelsus) or tirzepatide (Mounjaro), it is the single most important lab test for monitoring the medication's effectiveness on blood sugar.
Consult your healthcare provider before starting any medication. Targets and testing frequency should be personalised by your treating doctor — this guide is educational only.
| HbA1c (%) | What It Means |
|---|---|
| Below 5.7 | Normal |
| 5.7 to 6.4 | Prediabetes |
| 6.5 and above | Diabetes (diagnostic threshold) |
| 7.0 | Standard treatment target for most diabetics |
| 8.0 | Acceptable for elderly or those with hypoglycaemia risk |
| Above 9.0 | Poorly controlled — high complication risk |
| Above 10.0 | Urgent treatment escalation needed |
Important for Indian patients: Multiple studies — including data from the Madras Diabetes Research Foundation and ICMR — show that Indians develop diabetes complications at lower HbA1c levels than Western populations. This means Indian targets may be interpreted more stringently. Do not assume a Western-published "acceptable" range applies unchanged to your situation.
The RSSDI (Research Society for the Study of Diabetes in India) and ADA (American Diabetes Association) both recommend:
If you have been prescribed GLP-1 for prediabetes (HbA1c 5.7-6.4 %), the goal is typically to bring HbA1c below 5.7 % — into the normal range. Clinical trials show this is achievable in many patients within 6-12 months.
If you are using GLP-1 purely for weight management with normal HbA1c (below 5.7 %), monitoring annually is usually sufficient. Weight loss itself improves insulin sensitivity and may bring prediabetic readings into normal range.
GLP-1 medications are among the most potent HbA1c-lowering agents available in India:
| Medication and Trial | Baseline HbA1c | Reduction | Source |
|---|---|---|---|
| Semaglutide 1 mg — SUSTAIN-7 | 8.2 % | minus 1.5 % | NEJM 2017 |
| Semaglutide 2 mg — SUSTAIN-7 | 8.2 % | minus 1.8 % | NEJM 2017 |
| Tirzepatide 5 mg — SURPASS-2 | 8.28 % | minus 1.87 % | NEJM 2021 |
| Tirzepatide 10 mg — SURPASS-2 | 8.28 % | minus 2.01 % | NEJM 2021 |
| Tirzepatide 15 mg — SURPASS-2 | 8.28 % | minus 2.30 % | NEJM 2021 |
Patients starting with HbA1c above 9-11 % often see reductions of 2-3 % or more. Patients starting at 7.5-8 % may see smaller absolute reductions but can still reach target.
4-6 weeks: Fasting blood glucose typically begins falling. Home glucometer readings may show lower morning numbers.
3 months: First meaningful HbA1c result worth testing. Expect 0.5-1 % reduction at starting dose.
6 months: At therapeutic dose, most patients see 1-2.5 % reduction from baseline.
12 months: Maximum HbA1c benefit is usually achieved by 12 months. Continued treatment maintains this benefit.
Do not judge effectiveness from a test at 6-8 weeks. HbA1c reflects 3 months of glucose history — an early result is not yet meaningful.
| Situation | Recommended Frequency |
|---|---|
| Newly started on GLP-1 | Every 3 months for the first year |
| Stable on GLP-1, at target | Every 6 months |
| After a dose change | 3 months after the change |
| HbA1c above target | Every 3 months until stable |
| Weight loss use, no diabetes | Annually |
In India, HbA1c testing costs Rs 300-600 at major chains (Thyrocare, Dr Lal Pathlabs, SRL, Metropolis). Some Tier-2 city labs charge Rs 150-200. The test is not covered under most health insurance policies in India but is essential — do not skip to save money.
Many patients test HbA1c 4-6 weeks after starting GLP-1 and are disappointed. HbA1c reflects a 3-month average — test at 3 months, not before. A 6-week result is misleading.
A fasting blood sugar of 95-110 mg/dL may look normal, but post-meal spikes — common in Indian high-carbohydrate diets — can drive HbA1c significantly higher. HbA1c captures the full picture including post-meal excursions.
Reaching HbA1c 7.0 % and stopping GLP-1 almost invariably leads to HbA1c rising again within 3-6 months. GLP-1 medications must be continued to maintain the benefit — they are long-term treatments, not short courses.
Diet changes amplify HbA1c reduction significantly. Patients who reduce refined carbohydrates — white rice, maida, added sugar — consistently show 0.5-1.0 % greater HbA1c reduction than those making no dietary changes on the same medication and dose.
If you take insulin alongside GLP-1 and HbA1c falls to 6.5 % or below, your doctor must proactively reduce your insulin dose. Failing to do this causes hypoglycaemia — a common and preventable problem in India where dual therapy is common.
If HbA1c has not reduced by at least 0.5 % after 6 months at a stable therapeutic dose, discuss with your doctor:
True GLP-1 non-response affects approximately 10-15 % of patients. It does not mean you cannot benefit — adjusting dose, diet, or adding a complementary medication often resolves it.
HbA1c tells you the average. Home glucose monitoring (glucometer or CGM such as FreeStyle Libre) tells you the pattern — when spikes happen and what causes them. Used together, they give your doctor a complete picture.
A common pattern in Indian patients: HbA1c 7.5 % with fasting glucose 100 mg/dL but post-meal glucose of 220-280 mg/dL after roti and dal. The HbA1c is elevated by undetected post-meal spikes. Testing 2 hours after meals reveals this.
Q: My HbA1c was 9.2 % when I started Ozempic 6 months ago. It is now 7.8 %. Is this good progress? Yes — a 1.4 % reduction in 6 months is excellent. Continue treatment, discuss reaching 7.0 % as the next target with your doctor.
Q: I am not diabetic but taking Mounjaro for weight loss. My HbA1c is 5.5 %. Should I test regularly? Test annually. Your HbA1c is normal. Weight loss from Mounjaro also reduces your future risk of developing diabetes — a significant added benefit.
Q: My doctor in India said my HbA1c of 6.2 % is normal. Is that right? 6.2 % falls in the prediabetes range (5.7-6.4 %). While some doctors use older reference ranges, international guidelines classify this as prediabetes. Dietary changes and, in some cases, GLP-1 therapy, can prevent progression to diabetes.
Q: Can HbA1c give a wrong reading? Yes. Haemolytic anaemia, iron deficiency anaemia, and thalassaemia — all common in India — can falsely lower or raise HbA1c. If you have any of these conditions, discuss with your doctor whether fructosamine testing or CGM-derived glucose average is more appropriate.
